Oncternal Therapeutics Stock (NASDAQ: ONCT) stock price, news, charts, stock research, profile.
You can purchase shares of Oncternal Therapeutics (NASDAQ:ONCT) through any online brokerage.
Other companies in Oncternal Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Quoin Pharmaceuticals (NASDAQ:QNRX) and Palisade Bio (NASDAQ:PALI).
Oncternal Therapeutics has a consensus price target of $6.58.
The stock price for Oncternal Therapeutics (NASDAQ: ONCT) is $1.4023 last updated October 29, 2024 at 9:15 AM EDT.
There are no upcoming dividends for Oncternal Therapeutics.
Oncternal Therapeutics’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Oncternal Therapeutics.
Oncternal Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.